25 results
424B5
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
22 Jan 24
Prospectus supplement for primary offering
5:27pm
by the International Accounting Standards Board. Our consolidated financial statements are subject to the standards of the Public Company Accounting Oversight … of our Cayman Islands holding company.
Recent statements by the Chinese government have indicated an intent to exert more oversight and control over
424B3
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
20 Dec 23
Prospectus supplement
4:03pm
have indicated an intent to exert more oversight and control over offerings that are conducted overseas and/or foreign investments in China based … trading market in the United States may be prohibited if the Public Company Accounting Oversight Board (the “PCAOB”) determines that it cannot inspect
F-3
EX-23.1
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
5 Dec 23
Shelf registration (foreign)
4:06pm
Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal
F-3
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
5 Dec 23
Shelf registration (foreign)
4:06pm
statements by the Chinese government have indicated an intent to exert more oversight and control over offerings that are conducted overseas … exchange or in the over-the-counter trading market in the United States may be prohibited if the Public Company Accounting Oversight Board (the “PCAOB
6-K
EX-99.1
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
1 Sep 23
Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum
7:37am
for patients with cancer, where he provided oversight and direction to the operations of the business, research and development and execution
424B3
mxy8cuu4v7a
31 Mar 23
Prospectus supplement
4:04pm
424B3
r8sdwjfppgiuhdxrwja
2 Dec 22
Prospectus supplement
4:17pm
F-1
4eba58q944fdv
18 Nov 22
Registration statement (foreign)
5:39pm
20-F
f103czezm3zakzj
12 Aug 22
Annual report (foreign)
4:20pm
6-K
EX-99.1
a5yzxsn s03w944zq
26 Jul 22
Current report (foreign)
7:36am
424B4
e6ckh5
21 Jul 22
Prospectus supplement with pricing info
10:01am
FWP
ao7cm6g9z zsh
30 Jun 22
Free writing prospectus
9:04pm
FWP
zgb 7l5u9
30 Jun 22
Free writing prospectus
1:29pm
F-1/A
jvyic cs8jy
24 Jun 22
Registration statement (foreign) (amended)
9:47pm
F-1/A
og0nrsgv03he or
24 Jun 22
Registration statement (foreign) (amended)
8:21am
F-1/A
ql55kzzk oi
21 Jun 22
Registration statement (foreign) (amended)
6:26am
F-1/A
b7285n6od
6 Jun 22
Registration statement (foreign) (amended)
6:13pm
F-1/A
swvisyufgztp
11 May 22
Registration statement (foreign) (amended)
3:11pm
F-1/A
3r0taf80ts3z 3gi8
22 Apr 22
Registration statement (foreign) (amended)
6:09pm